TrueMark Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9M Buy
50,803
+6,603
+15% +$1.54M 1.62% 22
2026
Q1
$10.8M Buy
44,200
+2,627
+6% +$612K 2.1% 10
2025
Q4
$8.6M Buy
41,573
+2,982
+8% +$590K 1.64% 19
2025
Q3
$7.16M Buy
38,591
+7,349
+24% +$1.26M 1.24% 26
2025
Q2
$4.77M Sell
31,242
-7,300
-19% -$1.12M 1.03% 42
2025
Q1
$6.39M Buy
38,542
+3,735
+11% +$584K 1.67% 11
2024
Q4
$5.03M Buy
34,807
+11,399
+49% +$1.77M 1.61% 21
2024
Q3
$3.79M Buy
23,408
+5,651
+32% +$900K 1.22% 28
2024
Q2
$2.6M Buy
17,757
+8,618
+94% +$1.28M 0.89% 40
2024
Q1
$1.45M Sell
9,139
-164
-2% -$26.1K 1.33% 36
2023
Q4
$1.46M Buy
+9,303
New +$1.43M 1.45% 36

Other funds holding JNJ

TrueMark Investments's JNJ Position: Q2 2026 in Review

TrueMark Investments increased its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, buying an estimated $1.54M and bringing the position to 50,803 shares worth $12.9M. The position accounts for 1.62% of the portfolio, ranked #22.

TrueMark Investments first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • TrueMark Investments held 50,803 shares of Johnson & Johnson worth $12.9M as of Q2 2026.
  • TrueMark Investments bought 6,603 Johnson & Johnson shares in Q2 2026, an estimated $1.54M.
  • Johnson & Johnson made up 1.62% of TrueMark Investments's portfolio in Q2 2026, its #22 holding.
  • TrueMark Investments first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on TrueMark Investments's 13F filing for Q2 2026, filed 22 Jul 2026.